The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 26, 2018

Filed:

Jun. 16, 2015
Applicant:

Neurotech Usa, Inc., Cumberland, RI (US);

Inventors:

Vincent Ling, Walpole, MA (US);

Arne M. Nystuen, Cumberland, RI (US);

Weng Tao, Lincoln, RI (US);

Paul Francis Stabila, Coventry, RI (US);

Konrad A. Kauper, Sutton, MA (US);

Assignee:

Neurotech USA, Inc., Cumberland, RI (US);

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 35/30 (2015.01); A61K 39/395 (2006.01); A61K 9/00 (2006.01); A61L 27/38 (2006.01); A61K 38/17 (2006.01); A61K 35/12 (2015.01); C07K 14/71 (2006.01); A61K 48/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/3955 (2013.01); A61K 9/0051 (2013.01); A61K 35/12 (2013.01); A61K 35/30 (2013.01); A61K 38/179 (2013.01); A61L 27/38 (2013.01); C07K 14/71 (2013.01); A61K 48/005 (2013.01); A61L 2430/16 (2013.01); C07K 2319/30 (2013.01); C12N 2830/46 (2013.01);
Abstract

The invention provides nucleic acid and polypeptide sequences encoding antibody based scaffolds such as full antibodies, antibody Fab fragments, single chain antibodies, soluble VEGF receptor-Fc fusion proteins, and/or anti-angiogenic PDGF receptors. Also encompassed are cell lines encoding such anti-angiogenic antibody scaffolds, VEGF receptors, and/or PDGF receptors. The invention also provides encapsulated cell therapy devices that are capable of delivering such anti-angiogenic antibody scaffolds, VEGF receptors, and/or PDGF receptors as well as methods of using these devices to deliver the anti-angiogenic antibody scaffolds, VEGF receptors, and/or PDGF receptors to medically treat disorders in patients, including ophthalmic, vascular, inflammatory, and cell proliferation diseases.


Find Patent Forward Citations

Loading…